S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

TherapeuticsMD Insider Trades

-0.03 (-4.93%)
(As of 11/26/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
2.75 million shs
Average Volume
8.26 million shs
Market Capitalization
$244.97 million
P/E Ratio
Dividend Yield

TherapeuticsMD (NASDAQ:TXMD) Insider Buying and Selling Activity

Insider Ownership

Number Of
Insiders Buying
(Last 12 Months)

Amount Of
Insider Buying
(Last 12 Months)
$1.28 M

Number Of
Insiders Selling
(Last 12 Months)

Amount Of
Insider Selling
(Last 12 Months)
$225.12 K

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get TXMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling TherapeuticsMD stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TherapeuticsMD (NASDAQ TXMD) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2021Cooper C CollinsDirectorBuy1,000,000$0.58$580,000.00  
8/18/2021Cooper C CollinsDirectorBuy900,000$0.72$648,000.00  
8/16/2021Paul BisaroDirectorBuy50,000$0.79$39,500.00196,864  
8/13/2021Tommy G. ThompsonDirectorBuy11,000$0.87$9,570.00148,851  
8/12/2021James DareccaCFOSell93,337$0.87$81,203.19  
5/14/2021Tommy G ThompsonDirectorBuy5,000$1.06$5,300.003,555  
5/11/2021Edward BorkowskiEVPSell44,252$1.04$46,022.08103,500  
5/11/2021Marlan D. WalkerGeneral CounselSell21,592$1.04$22,455.6850,500  
5/11/2021Michael C. DoneganCAOSell4,842$1.04$5,035.6819,000  
5/11/2021Robert G FinizioCEOSell67,697$1.04$70,404.8818,059,334  
6/5/2020Robert G FinizioCEOBuy30,000$1.15$34,500.0018,335,964  
6/4/2020Tommy G ThompsonDirectorBuy8,700$1.13$9,831.003,555  
10/25/2019Brian BernickDirectorBuy36,000$2.75$99,000.0098,000  
10/25/2019John C.K. Iv MilliganInsiderBuy72,000$2.75$198,000.001,544,419  
10/23/2019Group L P ColumnMajor ShareholderBuy4,387$12.66$55,539.42
8/23/2019Angus C RussellDirectorBuy10,000$2.77$27,700.0093,500  
8/20/2019Robert G FinizioCEOBuy35,000$2.74$95,900.0018,253,964  
8/16/2019John C.K. Iv MilliganInsiderBuy10,000$2.93$29,300.001,472,419  
8/15/2019Angus C RussellDirectorBuy35,000$2.83$99,050.0073,500  
8/12/2019Jane F BarlowDirectorBuy3,144$3.18$9,997.923,144  
8/12/2019John C.K. Iv MilliganInsiderBuy15,000$3.16$47,400.001,472,419  
8/9/2019Brian BernickDirectorBuy10,000$2.87$28,700.0062,000  
8/9/2019Robert G FinizioCEOBuy52,405$2.96$155,118.8018,166,559  
5/13/2019Tommy G ThompsonDirectorBuy2,400$3.34$8,016.003,555  
2/27/2019Jules A MusingDirectorSell17,400$5.80$100,920.005,000  
12/20/2018Robert G FinizioCEOSell184,910$3.66$676,770.6018,458,559  
12/18/2018John C.K. Iv MilliganInsiderSell258,127$3.69$952,488.631,601,419  
12/13/2018Brian BernickDirectorSell183,310$4.15$760,736.5052,000  
12/7/2018Robert G FinizioCEOSell184,000$4.59$844,560.0018,366,559  
12/6/2018Daniel A CartwrightCFOSell40,000$4.57$182,800.0040,000  
12/6/2018John C.K. Iv MilliganInsiderSell258,000$4.77$1,230,660.001,601,419  
12/4/2018John C.K. Iv MilliganInsiderSell129,000$4.98$642,420.001,601,419  
12/3/2018Brian BernickDirectorSell182,800$5.07$926,796.00242,000  
11/30/2018Brian BernickDirectorSell91,400$4.96$453,344.00242,000  
11/29/2018John C.K. Iv MilliganInsiderSell258,128$4.96$1,280,314.881,601,419  
11/27/2018Robert G FinizioCEOSell184,000$4.83$888,720.0018,485,559  
11/20/2018Brian BernickDirectorSell182,800$4.74$866,472.00242,000  
11/15/2018John C.K. Iv MilliganInsiderSell258,000$4.90$1,264,200.001,601,419  
11/13/2018Robert G FinizioCEOSell184,000$4.77$877,680.0018,485,559  
11/9/2018Brian BernickDirectorSell182,800$4.88$892,064.00242,000  
11/7/2018Daniel A CartwrightCFOSell40,000$4.85$194,000.0040,000  
10/26/2018Robert G FinizioCEOSell184,000$5.28$971,520.0018,485,559  
10/24/2018John C.K. Iv MilliganInsiderSell250,000$5.35$1,337,500.001,597,419  
10/19/2018Brian BernickDirectorSell182,800$5.56$1,016,368.00242,000  
10/11/2018Robert G FinizioCEOSell92,000$5.65$519,800.0018,485,559  
10/10/2018John C.K. Iv MilliganInsiderSell250,000$5.85$1,462,500.001,597,419  
10/5/2018Brian BernickDirectorSell91,400$5.93$542,002.00242,000  
9/28/2018Brian BernickDirectorSell182,800$6.59$1,204,652.00242,000  
9/26/2018John C.K. Iv MilliganInsiderSell125,000$6.78$847,500.001,597,419  
9/21/2018Robert G FinizioCEOSell184,000$6.63$1,219,920.0018,485,559  
9/13/2018Brian BernickDirectorSell182,800$6.30$1,151,640.00242,000  
9/11/2018John C.K. Iv MilliganInsiderSell250,000$6.10$1,525,000.001,597,419  
9/7/2018Robert G FinizioCEOSell184,000$6.24$1,148,160.0018,485,559  
8/21/2018Tommy G ThompsonDirectorBuy4,000$5.53$22,120.003,555  
12/8/2017Tommy G ThompsonDirectorBuy5,000$6.21$31,050.003,555  
8/30/2017Tommy G ThompsonDirectorBuy5,000$5.99$29,950.003,555  
3/11/2016Cooper C CollinsDirectorBuy16,000$6.23$99,680.0036,000  
8/25/2015Angus C RussellDirectorBuy13,500$5.98$80,730.0048,500  
6/8/2015Mitchell KrassanEVPSell30,000$8.18$245,400.00  
5/12/2015Angus C RussellDirectorBuy35,000$6.15$215,250.00  
5/11/2015Tommy G ThompsonChairmanBuy6,000$6.09$36,540.00  
5/8/2015J Martin CarrollDirectorBuy10,000$6.11$61,100.00  
11/21/2014Daniel A CartwrightCFOSell40,000$3.91$156,400.00  
9/4/2014Tommy G ThompsonDirectorBuy1,757$5.44$9,558.08  
6/5/2014Cooper C CollinsDirectorBuy20,000$3.84$76,800.00  
5/9/2014Robert Lapenta, Jr.DirectorBuy5,000$3.66$18,300.0010,000  
5/8/2014Tommy ThompsonDirectorBuy14,000$3.57$49,980.00  
3/26/2014Brian BernickDirectorSell421,268$6.70$2,822,495.60297,000  
3/26/2014John C.K. Iv MilliganInsiderSell353,412$6.70$2,367,860.401,722,419  
3/26/2014Robert FinizioCEOSell982,053$6.70$6,579,755.1021,029,533  
3/10/2014Mitchell KrassanEVPSell7,500$7.73$57,975.00  
2/26/2014John C.K. Iv MilliganPresidentSell25,000$6.31$157,750.006,318,018  
2/21/2014Robert FinizioCEOSell50,000$6.17$308,500.0022,011,586  
2/12/2014Brian BernickDirectorSell31,250$6.16$192,500.00  
1/30/2014John C.K. Iv MilliganInsiderSell25,000$6.16$154,000.006,343,018  
1/23/2014Robert G FinizioCEOSell50,000$5.70$285,000.00  
1/13/2014Mitchell KrassanEVPSell7,500$5.73$42,975.00  
1/8/2014Brian BernickDirectorSell31,250$5.13$160,312.50  
8/26/2013Brian BernickInsiderSell1,600,000$1.55$2,480,000.00  
8/26/2013Jules A MusingDirectorBuy5,282$2.15$11,356.30  
6/14/2013Cooper C CollinsDirectorSell2,631,579$1.75$4,605,263.25  
(Data available from 1/1/2013 forward)

TherapeuticsMD (NASDAQ:TXMD) Insider Trade Frequently Asked Questions

Who is on TherapeuticsMD's Insider Roster?

The list of insiders at TherapeuticsMD includes Angus C Russell, Brian Bernick, Cooper C Collins, Daniel A Cartwright, Edward Borkowski, Group L P Column, James Darecca, Jane F Barlow, John C.K. Iv Milligan, Jules A Musing, Marlan D. Walker, Michael C. Donegan, Paul Bisaro, Robert G Finizio, Tommy G Thompson.Learn more on TXMD's insiders

What percentage of TherapeuticsMD stock is owned by insiders?

8.80% of TherapeuticsMD stock is owned by insiders. Learn more on TXMD's insider holdings

Which TherapeuticsMD insiders have been buying company stock?

The following insiders have purchased TherapeuticsMD stock in the last 24 months: Cooper C Collins ($1,228,000.00), Paul Bisaro ($39,500.00), Robert G Finizio ($34,500.00), and Tommy G Thompson ($15,131.00).

How much insider buying is happening at TherapeuticsMD?

Insiders have purchased a total of 2,004,700 TherapeuticsMD shares in the last 24 months for a total of $1,326,701.00 bought.

Which TherapeuticsMD insiders have been selling company stock?

The following insiders have sold TherapeuticsMD stock in the last 24 months: Edward Borkowski ($46,022.08), James Darecca ($81,203.19), Marlan D. Walker ($22,455.68), Michael C. Donegan ($5,035.68), and Robert G Finizio ($70,404.88).

How much insider selling is happening at TherapeuticsMD?

Insiders have sold a total of 231,720 TherapeuticsMD shares in the last 24 months for a total of $225,121.51 sold.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.